TY  - BOOK
AU  - 
AU  - 
TI  -  Immune Strategies for Gastrointestinal Cancer
T2  - Cancer Immunotherapy 
SN  -  978-3-031-39944-2 (eBook)
SN  -       266
PY  - 2023///
CY  - First Department of Medicine, Research Center for Immunotherapy (FZI) University Cancer Center Mainz, University Medical Center of the Johannes Gutenberg University Mainz Mainz, Germany |
PB  -       Springer Nature Switzerland AG |
N2  - This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers and discusses its future place in clinical practice.

Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients.

This book will appeal to a wide readership, including oncologists, health care professionals in general and biomedical scientists
UR  -  https://doi.org/10.1007/978-3-031-39944-2        
ER  -